A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 35/20 (2006.01) A61K 38/17 (2006.01) A61K 38/18 (2006.01) A61K 38/30 (2006.01) A61K 38/38 (2006.01) A61K 38/40 (2006.01) A61P 17/00 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2687123
The present application relates to methods for the treatment of eczema and uses of a dairy-derived composition. The treatment involves oral administration of 800 mg/day of a composition comprising TGF-ß1, TGF-ß2, IGF-1 and 60% (w/w) beta-lactoglobulin derived from whey.
La présente invention concerne des procédés de traitement d'eczéma et les utilisations d'une composition dérivée de produits laitiers. Le traitement implique l'administration par voie orale de 800 mg/jour d'une composition comprenant tgf-ß1, tgf-ß2, igf-1 et bêta-lactoglobuline à 60 % (poids/poids) dérivée de petit-lait.
Drouin Rejean
Juneau Christina
Moroni Olivier
Advitech Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Method for the treatment of atopic eczema does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of atopic eczema, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of atopic eczema will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1888380